Alamar Biosciences awarded General Counsel John L. Brottem 29,000 shares at $0 per share on September 14, alongside 85,000 derivative securities. The transaction left Brottem with 29,000 shares and 85,000 derivative securities, each representing 100.0% of his resulting holding in the respective category.

Key Highlights

  • The transaction occurred on September 14, 2026.
  • John L. Brottem received 85,000 derivative securities.
  • The derivative securities award represented 100.0% of his resulting holding in that category.

Alamar Biosciences, Inc. (NASDAQ: ALMR) awarded General Counsel John L. Brottem 29,000 shares at $0 per share. The award occurred on September 14, 2026, and left Brottem holding 29,000 shares.

Award Covers Shares and Derivative Securities

The transaction carried SEC transaction code A. Brottem’s resulting shares holding was 29,000, and the transaction represented about 100.0% of that resulting holding. The award also covered 85,000 derivative securities on September 14, 2026. Brottem held 85,000 derivative securities after that transaction, which represented about 100.0% of his resulting derivative securities holding. Transaction code A denotes an award, grant, or other Acquisition from the company.